(PDF) Clinical Validation of a Prognostic 11-Gene

Clinical Validation of a Prognostic 11-Gene Expression Profiling Score in Prospectively Collected FFPE Tissue of Patients With AJCC V8 Stage II Cutaneous Melanoma

European Journal of Cancer - United Kingdom

doi 10.1016/j.ejca.2019.10.027

Full Text

Open PDF

Abstract

Available in full text

Date

January 1, 2020

Authors

Teresa M.S. Amaral

Marie-Christine Hoffmann

Publisher

Elsevier BV

Related search

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Clinical Cancer Research

Cancer Research

Oncology

2019

English

Prognostic Significance of Tissue Proteomic Profiling in Stage I and II Cutaneous Malignant Melanoma of the Head and Neck

2018

English

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports

Multidisciplinary

2016

English

Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma

Journal of Investigative Dermatology

English

Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?

Journal of the American Academy of Dermatology

Dermatology

2019

English

Validation of the AJCC Prognostic Stage for HER2-positive Breast Cancer in the ShortHER Trial

BMC Medicine

Medicine

2019

English

A Gene-Expression Profiling Score for Prediction of Outcome in Patients With Follicular Lymphoma: A Retrospective Training and Validation Analysis in Three International Cohorts

The Lancet Oncology

Oncology

2018

English

Reply to “Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?”

Journal of the American Academy of Dermatology

Dermatology

2019

English

841 Clinical Experience With a Next-Generation Sequencing (NGS) Test for BRAF and NRAS Mutations Along With Gene Expression Profiling (GEP) in Cutaneous Melanoma (CM)

Journal of Investigative Dermatology

English

Amanote Research

Clinical Validation of a Prognostic 11-Gene Expression Profiling Score in Prospectively Collected FFPE Tissue of Patients With AJCC V8 Stage II Cutaneous Melanoma

European Journal of Cancer - United Kingdom

doi 10.1016/j.ejca.2019.10.027

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

Prognostic Significance of Tissue Proteomic Profiling in Stage I and II Cutaneous Malignant Melanoma of the Head and Neck

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Prognostic Impact of P62 Expression in Cutaneous Malignant Melanoma

Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?

Validation of the AJCC Prognostic Stage for HER2-positive Breast Cancer in the ShortHER Trial

A Gene-Expression Profiling Score for Prediction of Outcome in Patients With Follicular Lymphoma: A Retrospective Training and Validation Analysis in Three International Cohorts

Reply to “Use of a Prognostic Gene Expression Profile Test for T1 Cutaneous Melanoma: Will It Help or Harm Patients?”

841 Clinical Experience With a Next-Generation Sequencing (NGS) Test for BRAF and NRAS Mutations Along With Gene Expression Profiling (GEP) in Cutaneous Melanoma (CM)